nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—superior mesenteric artery—liver cancer	0.219	0.832	CbGeAlD
Tolmetin—TDO2—liver—liver cancer	0.0156	0.0594	CbGeAlD
Tolmetin—CXCL8—liver—liver cancer	0.00861	0.0327	CbGeAlD
Tolmetin—PTGS2—gall bladder—liver cancer	0.00779	0.0296	CbGeAlD
Tolmetin—Proteinuria—Sorafenib—liver cancer	0.00696	0.0395	CcSEcCtD
Tolmetin—Protein urine present—Sorafenib—liver cancer	0.00687	0.0389	CcSEcCtD
Tolmetin—Glossitis—Sorafenib—liver cancer	0.00664	0.0376	CcSEcCtD
Tolmetin—Blood pressure increased—Sorafenib—liver cancer	0.00612	0.0347	CcSEcCtD
Tolmetin—Indomethacin—PPARA—liver cancer	0.00539	0.603	CrCbGaD
Tolmetin—MPO—liver—liver cancer	0.00503	0.0191	CbGeAlD
Tolmetin—PTGS2—embryo—liver cancer	0.00494	0.0187	CbGeAlD
Tolmetin—Cardiac failure congestive—Sorafenib—liver cancer	0.0049	0.0278	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.004	0.0227	CcSEcCtD
Tolmetin—Gastritis—Sorafenib—liver cancer	0.00393	0.0223	CcSEcCtD
Tolmetin—Abdominal discomfort—Sorafenib—liver cancer	0.00368	0.0209	CcSEcCtD
Tolmetin—Weight decreased—Sorafenib—liver cancer	0.00347	0.0197	CcSEcCtD
Tolmetin—Renal failure—Sorafenib—liver cancer	0.00336	0.0191	CcSEcCtD
Tolmetin—Stomatitis—Sorafenib—liver cancer	0.00334	0.0189	CcSEcCtD
Tolmetin—Epistaxis—Sorafenib—liver cancer	0.00323	0.0183	CcSEcCtD
Tolmetin—Erythema multiforme—Sorafenib—liver cancer	0.0029	0.0165	CcSEcCtD
Tolmetin—Tinnitus—Sorafenib—liver cancer	0.00286	0.0162	CcSEcCtD
Tolmetin—Indomethacin—PPARG—liver cancer	0.00258	0.289	CrCbGaD
Tolmetin—Glossitis—Epirubicin—liver cancer	0.00245	0.0139	CcSEcCtD
Tolmetin—PTGS2—liver—liver cancer	0.00228	0.00867	CbGeAlD
Tolmetin—Glossitis—Doxorubicin—liver cancer	0.00227	0.0129	CcSEcCtD
Tolmetin—Anaphylactic shock—Sorafenib—liver cancer	0.00218	0.0124	CcSEcCtD
Tolmetin—Thrombocytopenia—Sorafenib—liver cancer	0.00214	0.0121	CcSEcCtD
Tolmetin—Blood urea increased—Epirubicin—liver cancer	0.00213	0.0121	CcSEcCtD
Tolmetin—Blood urea increased—Doxorubicin—liver cancer	0.00197	0.0112	CcSEcCtD
Tolmetin—Lymphadenopathy—Epirubicin—liver cancer	0.00192	0.0109	CcSEcCtD
Tolmetin—Dyspepsia—Sorafenib—liver cancer	0.00192	0.0109	CcSEcCtD
Tolmetin—Constipation—Sorafenib—liver cancer	0.00187	0.0106	CcSEcCtD
Tolmetin—Vascular purpura—Epirubicin—liver cancer	0.00183	0.0104	CcSEcCtD
Tolmetin—Cardiac failure congestive—Epirubicin—liver cancer	0.00181	0.0103	CcSEcCtD
Tolmetin—Gastrointestinal pain—Sorafenib—liver cancer	0.00178	0.0101	CcSEcCtD
Tolmetin—Lymphadenopathy—Doxorubicin—liver cancer	0.00178	0.0101	CcSEcCtD
Tolmetin—Urticaria—Sorafenib—liver cancer	0.00173	0.00983	CcSEcCtD
Tolmetin—Abdominal pain—Sorafenib—liver cancer	0.00173	0.00978	CcSEcCtD
Tolmetin—Body temperature increased—Sorafenib—liver cancer	0.00173	0.00978	CcSEcCtD
Tolmetin—Purpura—Epirubicin—liver cancer	0.0017	0.00965	CcSEcCtD
Tolmetin—Vascular purpura—Doxorubicin—liver cancer	0.0017	0.00962	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Epirubicin—liver cancer	0.0017	0.00961	CcSEcCtD
Tolmetin—Cardiac failure congestive—Doxorubicin—liver cancer	0.00167	0.00949	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00164	0.0093	CcSEcCtD
Tolmetin—Purpura—Doxorubicin—liver cancer	0.00158	0.00893	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00157	0.00889	CcSEcCtD
Tolmetin—Asthenia—Sorafenib—liver cancer	0.00157	0.00888	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00152	0.00861	CcSEcCtD
Tolmetin—Diarrhoea—Sorafenib—liver cancer	0.00149	0.00847	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00148	0.00838	CcSEcCtD
Tolmetin—Gastritis—Epirubicin—liver cancer	0.00145	0.00823	CcSEcCtD
Tolmetin—Dizziness—Sorafenib—liver cancer	0.00144	0.00818	CcSEcCtD
Tolmetin—Vomiting—Sorafenib—liver cancer	0.00139	0.00787	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00137	0.00775	CcSEcCtD
Tolmetin—Headache—Sorafenib—liver cancer	0.00137	0.00775	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—liver cancer	0.00134	0.00762	CcSEcCtD
Tolmetin—Dysuria—Epirubicin—liver cancer	0.00133	0.00752	CcSEcCtD
Tolmetin—Nausea—Sorafenib—liver cancer	0.0013	0.00735	CcSEcCtD
Tolmetin—Weight increased—Epirubicin—liver cancer	0.00129	0.00732	CcSEcCtD
Tolmetin—Weight decreased—Epirubicin—liver cancer	0.00128	0.00728	CcSEcCtD
Tolmetin—Drowsiness—Epirubicin—liver cancer	0.00126	0.00717	CcSEcCtD
Tolmetin—Renal failure—Epirubicin—liver cancer	0.00124	0.00705	CcSEcCtD
Tolmetin—Stomatitis—Epirubicin—liver cancer	0.00123	0.00699	CcSEcCtD
Tolmetin—Urinary tract infection—Epirubicin—liver cancer	0.00123	0.00697	CcSEcCtD
Tolmetin—Dysuria—Doxorubicin—liver cancer	0.00123	0.00696	CcSEcCtD
Tolmetin—Haematuria—Epirubicin—liver cancer	0.00121	0.00684	CcSEcCtD
Tolmetin—Weight increased—Doxorubicin—liver cancer	0.00119	0.00677	CcSEcCtD
Tolmetin—Epistaxis—Epirubicin—liver cancer	0.00119	0.00676	CcSEcCtD
Tolmetin—Weight decreased—Doxorubicin—liver cancer	0.00119	0.00673	CcSEcCtD
Tolmetin—Agranulocytosis—Epirubicin—liver cancer	0.00118	0.00669	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—liver cancer	0.00117	0.00663	CcSEcCtD
Tolmetin—Renal failure—Doxorubicin—liver cancer	0.00115	0.00652	CcSEcCtD
Tolmetin—Stomatitis—Doxorubicin—liver cancer	0.00114	0.00647	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—liver cancer	0.00114	0.00645	CcSEcCtD
Tolmetin—Hepatitis—Epirubicin—liver cancer	0.00114	0.00644	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—liver cancer	0.00112	0.00633	CcSEcCtD
Tolmetin—Epistaxis—Doxorubicin—liver cancer	0.0011	0.00626	CcSEcCtD
Tolmetin—Visual impairment—Epirubicin—liver cancer	0.00109	0.0062	CcSEcCtD
Tolmetin—Agranulocytosis—Doxorubicin—liver cancer	0.00109	0.00619	CcSEcCtD
Tolmetin—Erythema multiforme—Epirubicin—liver cancer	0.00107	0.00609	CcSEcCtD
Tolmetin—Tinnitus—Epirubicin—liver cancer	0.00106	0.006	CcSEcCtD
Tolmetin—Hepatitis—Doxorubicin—liver cancer	0.00105	0.00596	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—liver cancer	0.00101	0.00574	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—liver cancer	0.000993	0.00563	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—liver cancer	0.000979	0.00555	CcSEcCtD
Tolmetin—Flatulence—Epirubicin—liver cancer	0.000974	0.00552	CcSEcCtD
Tolmetin—Indomethacin—ALB—liver cancer	0.00097	0.109	CrCbGaD
Tolmetin—Flatulence—Doxorubicin—liver cancer	0.000901	0.00511	CcSEcCtD
Tolmetin—Chest pain—Epirubicin—liver cancer	0.000841	0.00477	CcSEcCtD
Tolmetin—Oedema—Epirubicin—liver cancer	0.000807	0.00457	CcSEcCtD
Tolmetin—Anaphylactic shock—Epirubicin—liver cancer	0.000807	0.00457	CcSEcCtD
Tolmetin—Thrombocytopenia—Epirubicin—liver cancer	0.00079	0.00448	CcSEcCtD
Tolmetin—Chest pain—Doxorubicin—liver cancer	0.000779	0.00441	CcSEcCtD
Tolmetin—Oedema—Doxorubicin—liver cancer	0.000746	0.00423	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—liver cancer	0.000746	0.00423	CcSEcCtD
Tolmetin—Thrombocytopenia—Doxorubicin—liver cancer	0.000731	0.00414	CcSEcCtD
Tolmetin—Somnolence—Epirubicin—liver cancer	0.000717	0.00407	CcSEcCtD
Tolmetin—Dyspepsia—Epirubicin—liver cancer	0.00071	0.00403	CcSEcCtD
Tolmetin—Constipation—Epirubicin—liver cancer	0.00069	0.00391	CcSEcCtD
Tolmetin—Somnolence—Doxorubicin—liver cancer	0.000663	0.00376	CcSEcCtD
Tolmetin—Gastrointestinal pain—Epirubicin—liver cancer	0.00066	0.00374	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—liver cancer	0.000657	0.00372	CcSEcCtD
Tolmetin—Urticaria—Epirubicin—liver cancer	0.000641	0.00363	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—liver cancer	0.000638	0.00362	CcSEcCtD
Tolmetin—Abdominal pain—Epirubicin—liver cancer	0.000638	0.00361	CcSEcCtD
Tolmetin—Body temperature increased—Epirubicin—liver cancer	0.000638	0.00361	CcSEcCtD
Tolmetin—Gastrointestinal pain—Doxorubicin—liver cancer	0.00061	0.00346	CcSEcCtD
Tolmetin—Urticaria—Doxorubicin—liver cancer	0.000593	0.00336	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—liver cancer	0.00059	0.00334	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—liver cancer	0.00059	0.00334	CcSEcCtD
Tolmetin—Asthenia—Epirubicin—liver cancer	0.000579	0.00328	CcSEcCtD
Tolmetin—Diarrhoea—Epirubicin—liver cancer	0.000552	0.00313	CcSEcCtD
Tolmetin—Asthenia—Doxorubicin—liver cancer	0.000535	0.00304	CcSEcCtD
Tolmetin—Dizziness—Epirubicin—liver cancer	0.000533	0.00302	CcSEcCtD
Tolmetin—Vomiting—Epirubicin—liver cancer	0.000513	0.00291	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—liver cancer	0.000511	0.00289	CcSEcCtD
Tolmetin—Headache—Epirubicin—liver cancer	0.000505	0.00286	CcSEcCtD
Tolmetin—Dizziness—Doxorubicin—liver cancer	0.000494	0.0028	CcSEcCtD
Tolmetin—Nausea—Epirubicin—liver cancer	0.000479	0.00272	CcSEcCtD
Tolmetin—Vomiting—Doxorubicin—liver cancer	0.000475	0.00269	CcSEcCtD
Tolmetin—Headache—Doxorubicin—liver cancer	0.000468	0.00265	CcSEcCtD
Tolmetin—Nausea—Doxorubicin—liver cancer	0.000443	0.00251	CcSEcCtD
Tolmetin—TDO2—Metabolism—PPARA—liver cancer	0.000279	0.000506	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—liver cancer	0.000278	0.000504	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EPT1—liver cancer	0.00027	0.000489	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000269	0.000489	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—F2—liver cancer	0.000268	0.000487	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—liver cancer	0.000267	0.000484	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—JUN—liver cancer	0.000264	0.00048	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—liver cancer	0.000263	0.000477	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—IGF2—liver cancer	0.000258	0.000467	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1A—liver cancer	0.000256	0.000465	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TAT—liver cancer	0.000256	0.000464	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000251	0.000456	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK8—liver cancer	0.00025	0.000454	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—liver cancer	0.000246	0.000447	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—liver cancer	0.000243	0.000442	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CG—liver cancer	0.000239	0.000433	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000236	0.000429	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000233	0.000422	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000232	0.000421	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000232	0.00042	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000231	0.00042	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—liver cancer	0.000231	0.000419	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—liver cancer	0.000231	0.000419	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PPARG—liver cancer	0.000231	0.000418	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—STAT3—liver cancer	0.000229	0.000415	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000228	0.000414	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—UGDH—liver cancer	0.000228	0.000413	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000227	0.000412	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000227	0.000411	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000225	0.000409	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FST—liver cancer	0.000222	0.000404	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.000221	0.000401	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000219	0.000398	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PRKCE—liver cancer	0.000218	0.000396	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.000215	0.00039	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000215	0.000389	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EPT1—liver cancer	0.000214	0.000388	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000212	0.000385	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TRIO—liver cancer	0.000212	0.000385	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—liver cancer	0.000211	0.000384	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CD—liver cancer	0.00021	0.000381	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000209	0.000379	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—liver cancer	0.000207	0.000376	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR4—liver cancer	0.000203	0.000369	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TAT—liver cancer	0.000203	0.000368	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.0002	0.000362	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PRKCE—liver cancer	0.000198	0.00036	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000196	0.000355	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CSF2—liver cancer	0.000193	0.00035	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—F2—liver cancer	0.000189	0.000342	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000188	0.000341	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CB—liver cancer	0.000183	0.000332	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000183	0.000332	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000177	0.000322	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000177	0.000321	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CSF2—liver cancer	0.000175	0.000318	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—liver cancer	0.000175	0.000317	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CPT1B—liver cancer	0.000174	0.000315	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GLUL—liver cancer	0.000174	0.000315	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000172	0.000312	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000169	0.000306	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NR1H4—liver cancer	0.000168	0.000304	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000165	0.0003	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTA3—liver cancer	0.000165	0.000299	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LTF—liver cancer	0.000165	0.000299	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADAM17—liver cancer	0.000161	0.000292	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—liver cancer	0.00016	0.00029	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—liver cancer	0.00016	0.00029	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000158	0.000287	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000158	0.000286	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000155	0.00028	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—F2—liver cancer	0.000152	0.000275	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSMD10—liver cancer	0.000151	0.000274	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSMA4—liver cancer	0.000151	0.000274	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTA4—liver cancer	0.000151	0.000273	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00015	0.000273	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00015	0.000272	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000149	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000149	0.00027	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000147	0.000267	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTA2—liver cancer	0.000147	0.000266	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.000146	0.000264	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000146	0.000264	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CG—liver cancer	0.000145	0.000263	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000142	0.000258	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTA1—liver cancer	0.000142	0.000257	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NAT2—liver cancer	0.00014	0.000254	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CPT1B—liver cancer	0.000138	0.00025	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GLUL—liver cancer	0.000138	0.00025	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—F2—liver cancer	0.000138	0.00025	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000135	0.000244	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDOB—liver cancer	0.000134	0.000244	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000133	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NR1H4—liver cancer	0.000133	0.000241	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CG—liver cancer	0.000132	0.000239	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000131	0.000238	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTA3—liver cancer	0.000131	0.000237	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CRABP1—liver cancer	0.000128	0.000232	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CD—liver cancer	0.000128	0.000231	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ALDOB—liver cancer	0.000127	0.000231	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—liver cancer	0.000123	0.000223	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000121	0.000219	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.00012	0.000218	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTA4—liver cancer	0.00012	0.000217	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	0.000118	0.000213	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKCE—liver cancer	0.000117	0.000213	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000117	0.000212	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTA2—liver cancer	0.000117	0.000211	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CD—liver cancer	0.000116	0.00021	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000115	0.000209	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTA1—liver cancer	0.000112	0.000204	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000112	0.000204	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HPGDS—liver cancer	0.000112	0.000203	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—liver cancer	0.000112	0.000202	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000111	0.000202	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000111	0.000202	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NAT2—liver cancer	0.000111	0.000202	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CB—liver cancer	0.000111	0.000202	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF2—liver cancer	0.000111	0.000201	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000107	0.000194	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDOB—liver cancer	0.000107	0.000193	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000106	0.000193	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CSF2—liver cancer	0.000104	0.000188	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RAF1—liver cancer	0.000103	0.000188	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000102	0.000186	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—H2AFX—liver cancer	0.000102	0.000185	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—liver cancer	0.000102	0.000185	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CRABP1—liver cancer	0.000102	0.000184	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000101	0.000184	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CB—liver cancer	0.000101	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ADAM17—liver cancer	0.000101	0.000183	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.0001	0.000182	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSMD10—liver cancer	9.98e-05	0.000181	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSMA4—liver cancer	9.98e-05	0.000181	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	9.91e-05	0.00018	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GOT2—liver cancer	9.71e-05	0.000176	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSMA4—liver cancer	9.46e-05	0.000172	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSMD10—liver cancer	9.46e-05	0.000172	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—liver cancer	9.27e-05	0.000168	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TERT—liver cancer	9.24e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GOT2—liver cancer	9.2e-05	0.000167	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.16e-05	0.000166	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP2E1—liver cancer	9.13e-05	0.000166	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—liver cancer	9.12e-05	0.000165	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HPGDS—liver cancer	8.89e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.84e-05	0.00016	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.84e-05	0.00016	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYCS—liver cancer	8.54e-05	0.000155	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KDR—liver cancer	8.45e-05	0.000153	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK14—liver cancer	8.39e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GOT1—liver cancer	8.38e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GGT1—liver cancer	8.38e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	8.37e-05	0.000152	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ESR1—liver cancer	8.23e-05	0.000149	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—F2—liver cancer	8.13e-05	0.000148	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.05e-05	0.000146	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.95e-05	0.000144	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GOT1—liver cancer	7.94e-05	0.000144	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSMA4—liver cancer	7.92e-05	0.000144	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSMD10—liver cancer	7.92e-05	0.000144	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—liver cancer	7.78e-05	0.000141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—liver cancer	7.78e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GOT2—liver cancer	7.71e-05	0.00014	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTP1—liver cancer	7.53e-05	0.000137	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMOX1—liver cancer	7.42e-05	0.000135	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRKCE—liver cancer	7.33e-05	0.000133	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BRAF—liver cancer	7.32e-05	0.000133	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2E1—liver cancer	7.25e-05	0.000131	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.02e-05	0.000127	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—liver cancer	6.92e-05	0.000125	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CD—liver cancer	6.84e-05	0.000124	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYCS—liver cancer	6.78e-05	0.000123	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—liver cancer	6.78e-05	0.000123	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SERPINE1—liver cancer	6.77e-05	0.000123	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—liver cancer	6.7e-05	0.000122	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GOT1—liver cancer	6.65e-05	0.000121	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GGT1—liver cancer	6.65e-05	0.000121	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1A1—liver cancer	6.56e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Disease—H2AFX—liver cancer	6.39e-05	0.000116	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—liver cancer	6.15e-05	0.000112	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—liver cancer	6.11e-05	0.000111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAF1—liver cancer	6.11e-05	0.000111	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARA—liver cancer	6e-05	0.000109	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTP1—liver cancer	5.98e-05	0.000108	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MTOR—liver cancer	5.96e-05	0.000108	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CB—liver cancer	5.96e-05	0.000108	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMOX1—liver cancer	5.89e-05	0.000107	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—liver cancer	5.79e-05	0.000105	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TERT—liver cancer	5.78e-05	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—liver cancer	5.69e-05	0.000103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—liver cancer	5.6e-05	0.000102	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—liver cancer	5.54e-05	0.0001	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—liver cancer	5.49e-05	9.96e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—liver cancer	5.49e-05	9.95e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—liver cancer	5.48e-05	9.94e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—liver cancer	5.45e-05	9.89e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.39e-05	9.77e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—liver cancer	5.34e-05	9.69e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JUN—liver cancer	5.33e-05	9.67e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—liver cancer	5.29e-05	9.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1A1—liver cancer	5.21e-05	9.44e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—liver cancer	5.18e-05	9.4e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—liver cancer	5.17e-05	9.37e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—liver cancer	5.14e-05	9.32e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK8—liver cancer	5.04e-05	9.15e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—liver cancer	5.03e-05	9.12e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—liver cancer	4.96e-05	8.99e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—liver cancer	4.87e-05	8.83e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—liver cancer	4.85e-05	8.8e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARA—liver cancer	4.76e-05	8.64e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—liver cancer	4.65e-05	8.44e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—liver cancer	4.61e-05	8.36e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BRAF—liver cancer	4.58e-05	8.3e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CD—liver cancer	4.52e-05	8.19e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—liver cancer	4.46e-05	8.09e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—liver cancer	4.28e-05	7.77e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CD—liver cancer	4.28e-05	7.76e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.28e-05	7.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—liver cancer	4.27e-05	7.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SERPINE1—liver cancer	4.23e-05	7.68e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—liver cancer	4.08e-05	7.4e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—liver cancer	3.96e-05	7.18e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CB—liver cancer	3.94e-05	7.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—liver cancer	3.94e-05	7.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RAF1—liver cancer	3.82e-05	6.93e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CB—liver cancer	3.73e-05	6.77e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTOR—liver cancer	3.73e-05	6.77e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—liver cancer	3.64e-05	6.6e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CD—liver cancer	3.58e-05	6.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—liver cancer	3.54e-05	6.42e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—liver cancer	3.52e-05	6.38e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—liver cancer	3.5e-05	6.35e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—liver cancer	3.36e-05	6.1e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—liver cancer	3.31e-05	6e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—liver cancer	3.23e-05	5.86e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—liver cancer	3.22e-05	5.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CB—liver cancer	3.12e-05	5.67e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—liver cancer	2.97e-05	5.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—liver cancer	2.88e-05	5.23e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—liver cancer	2.68e-05	4.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—liver cancer	2.67e-05	4.85e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—liver cancer	2.48e-05	4.49e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—liver cancer	2.4e-05	4.35e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—liver cancer	2.27e-05	4.13e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—liver cancer	2.1e-05	3.82e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—liver cancer	2.01e-05	3.65e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—liver cancer	1.96e-05	3.56e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—liver cancer	1.9e-05	3.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—liver cancer	1.86e-05	3.37e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—liver cancer	1.56e-05	2.82e-05	CbGpPWpGaD
